Individual patient data (IPD) analysis of progression-free survival (PFS) versus overall survival (OS) as an endpoint for metastatic colorectal cancer (mCRC) in modern trials: Findings from the 16,700 patients (pts) ARCAD database.

被引：0
|
作者：
Shi, Qian
De Gramont, Aimery
Buyse, Marc E.
Grothey, Axel
Schmoll, Hans-Joachim
Seymour, Matthew T.
Adams, Richard A.
Saltz, Leonard
Goldberg, Richard M.
Punt, Cornelis J. A.
Douillard, Jean-Yves
Hecht, J. Randolph
Hurwitz, Herbert
Diaz-Rubio, Eduardo
Porschen, Rainer
Tebbutt, Niall C.
Fuchs, Charles S.
Souglakos, John
Falcone, Alfredo
Sargent, Daniel J.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Hosp St Antoine, Paris, France
[3] Int Inst Drug Dev, Louvain, Belgium
[4] Univ Halle Wittenberg, D-06108 Halle, Germany
[5] Canc Res UK Clin Ctr, Leeds, W Yorkshire, England
[6] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[8] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[9] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[10] ICO Ctr Rene Gauducheau, St Herblain, France
[11] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[12] Duke Univ, Med Ctr, Durham, NC USA
[13] Hosp Clin San Carlos, Madrid, Spain
[14] Klinikum Bremen Ost, Bremen, Germany
[15] Austin Hlth, Heidelberg, Vic, Australia
[16] Univ Melbourne, Heidelberg, Vic, Australia
[17] Dana Farber Canc Inst, Boston, MA 02115 USA
[18] Univ Crete, Sch Med, Iraklion, Greece
[19] Santa Chiara Hosp, Pisa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3533
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (aEGFR) therapy.
    Lee, Michael Sangmin
    Advani, Shailesh M.
    Morris, Jeffrey
    Jiang, Zhi-Qin
    Manyam, Ganiraju C.
    Menter, David
    Broom, Bradley McIntosh
    Eng, Cathy
    Overman, Michael J.
    Maru, Dipen M.
    Hamilton, Stanley R.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Real-world data on overall and progression-free survival for patients (pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO-UK)
    Marti, F. E. Marti
    Raman, R.
    Brady, D.
    Walker, G.
    Dewdney, A.
    Lau, S. C.
    Agarwal, R.
    Bridgewater, J. A.
    Lo, N.
    McLeod, D.
    Chauvet, M-A.
    ANNALS OF ONCOLOGY, 2024, 35 : S48 - S48
  • [33] Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance).
    Van Blarigan, Erin
    Ma, Chao
    Ou, Fang-Shu
    Venook, Alan P.
    Ng, Kimmie
    Niedzwiecki, Donna
    Giovannucci, Edward L.
    Lenz, Heinz-Josef
    Innocenti, Federico
    Shaw, James Edward
    Polite, Blase N.
    Hochster, Howard S.
    Goldberg, Richard M.
    Mayer, Robert J.
    O'Reilly, Eileen Mary
    Fuchs, Charles S.
    Meyerhardt, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Prognostic value of neutrophil-to-lymphocyte ratio (NLR) on overall survival (OS), progression free survival (PFS) and disease control rate (DCR) in patients with metastatic colorectal cancer (mCRC) from the RECOURSE study.
    Argiles, Guillem
    Yoshino, Takayuki
    Ohtsu, Atsushi
    Mayer, Robert J.
    Winkler, Robert
    Amellal, Nadia
    Fougeray, Ronan
    Kanehisa, Akira
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [35] SENSITIVITY ANALYSES OF PROGRESSION-FREE SURVIVAL (PFS) OF AFLIBERCEPT-FOLFIRI VERSUS PLACEBO-FOLFIRI IN METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM THE VELOUR STUDY
    Van Cutsem, E.
    Tabernero, J.
    Lakomy, R.
    Prausova, J.
    Ruff, P.
    Moiseyenko, V.
    Ferry, D.
    Boelle, E.
    McKendrick, J.
    Allegra, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 198 - 199
  • [36] Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database
    Ou, Fang-Shu
    Ahn, Daniel H.
    Dixon, Jesse G.
    Grothey, Axel
    Lou, Yiyue
    Kasi, Pashtoon M.
    Hubbard, Joleen M.
    Van Cutsem, Eric
    Saltz, Leonard B.
    Schmoll, Hans-Joachim
    Goldberg, Richard M.
    Venook, Alan P.
    Hoff, Paulo
    Douillard, Jean-Yves
    Hecht, J. Randolph
    Hurwitz, Herbert
    Punt, Cornelis J. A.
    Koopman, Miriam
    Bokemeyer, Carsten
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Tebbutt, Niall C.
    Cremolini, Chiara
    Kabbinavar, Fairooz F.
    Bekaii-Saab, Tanios
    Chibaudel, Benoist
    Yoshino, Takayuki
    Zalcberg, John
    Adams, Richard A.
    de Gramont, Aimery
    Shi, Qian
    CANCERS, 2023, 15 (16)
  • [37] Correlation between progression-free and overall survival in patients with classical Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized GHSG trials
    Broeckelmann, P.
    Mueller, H.
    Gillessen, S.
    Jacob, A. S.
    Momotow, J.
    Damaschin, C.
    Ferdinandus, J.
    Yang, X.
    Fuchs, M.
    Kobe, C.
    Eich, H. T.
    Engert, A.
    Borchmann, P.
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 110 - 110
  • [38] Response rate using conventional criteria is a poor surrogate for clinical benefit on progression-free (PFS) and overall survival (OS) in metastatic colorectal cancer (mCRC): A comparative analysis of N9741 and AVF2107.
    Grothey, A.
    Hedrick, E. E.
    Mass, R. D.
    Sarkar, S.
    Ramanathan, R. K.
    Hurwitz, H.
    Goldberg, R. M.
    Sargent, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 150S - 150S
  • [39] Re-evaluating disease-free survival (DFS) as an endpoint versus overall survival (OS) in adjuvant colon cancer (CC) trials with chemotherapy plus /- biologics: An updated surrogacy analysis based on 18,886 patients (pts) from the Accent database.
    Shi, Qian
    De Gramont, Aimery
    Dixon, Jesse G.
    Yin, Jun
    Van Cutsem, Eric
    Taieb, Julien
    Alberts, Steven R.
    Wolmark, Norman
    Schmoll, Hans-Joachim Hans-joachim
    Saltz, Leonard B.
    Goldberg, Richard M.
    Kerr, Rachel
    Lonardi, Sara
    Yoshino, Takayuki
    Yothers, Greg
    Grothey, Axel
    Andre, Thierry
    Salem, Mohamed E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan
    Shiota, Masaki
    De Moor, Raf
    Koroki, Yosuke
    Yu, Dae Young
    Wu, David Bin-Chia
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (08) : 1351 - 1359
12345